US Senator Flags Poor-Quality Drug Imports From India And China, Urges Stricter FDA Checks

US Senator Jim Banks has voiced serious concerns over the quality of pharmaceutical imports from India and China, urging the Food and Drug Administration (FDA) to intensify scrutiny of overseas manufacturing sites.In a letter addressed to FDA Commissioner Martin Makary, the senator stressed that American consumers depend on the agency to safeguard the integrity of the nation’s drug supply chain,
US Senator Jim Banks has voiced serious concerns over the quality of pharmaceutical imports from India and China, urging the Food and Drug Administration (FDA) to intensify scrutiny of overseas manufacturing sites.In a letter addressed to FDA Commissioner Martin Makary, the senator stressed that American consumers depend on the agency to safeguard the integrity of the nation’s drug supply chain,
Go to Source